Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 61Carcinoma, Renal Cell 39Neoplasm Metastasis 38Neoplasms 24Kidney Neoplasms 20Neuroendocrine Tumors 19Recurrence 16Prostatic Neoplasms 15Head and Neck Neoplasms 13Tuberous Sclerosis 12Triple Negative Breast Neoplasms 12Lymphoma, Mantle-Cell 11Hodgkin Disease 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Large B-Cell, Diffuse 10Lymphoma 10Colorectal Neoplasms 10Waldenstrom Macroglobulinemia 9Stomach Neoplasms 9Multiple Myeloma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Glioma 9Glioblastoma 9Brain Neoplasms 9Sarcoma 8Pancreatic Neoplasms 8Melanoma 8Lymphoma, Follicular 8Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8

Interventions

Cetuximab 5pembrolizumab 3Paclitaxel 3Docetaxel 3Radiotherapy, Intensity-Modulated 2Radiotherapy 2Nivolumab 2Cyclophosphamide 2Cisplatin 2Carboplatin 2temsirolimus 1poly ICLC 1fludarabine phosphate 1fludarabine 1abemaciclib 1Vorinostat 1Taxes 1Sorafenib 1Risk Factors 1Ribavirin 1Radiosurgery 1Radiation 1Pemetrexed 1Oxaliplatin 1Nimorazole 1Mitomycins 1Mitomycin 1Jogging 1Injections 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Squamous Cell × Everolimus × Clear all
NCT01111058 2020-04-07

Everolimus Versus Placebo in Head and Neck Cancer

University of Chicago

Phase 2 Terminated
52 enrolled 13 charts
Head & Neck

Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡